References
- Tayab Z R, Hochhaus G. Pharmacokinetic/pharmacodynamic evaluation of inhalation drugs: application to targeted pulmonary delivery systems. Expert Opin Drug Deliv 2005; 2(3)519–532
- Barnes P J, Pedersen S, Busse W W. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 1998; 157: S1–53, (3 Pt 2)
- Leung D Y, Bloom J W. Update on glucocorticoid action and resistance. J Allergy Clin Immunol 2003; 111(1)3–22
- Allen D B, Bielory L, Derendorf H, Dluhy R, Colice G L, Szefler S J. Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol 2003; 112(3 Suppl)S1–40
- Derendorf H. Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety. Respir Med 1997; 91(Suppl A)22–8
- Rohatagi S, Arya V, Zech K, Nave R, Hochhaus G, Jensen B K, Barrett J S. Population pharmacokinetics and pharmacodynamics of ciclesonide. J Clin Pharmacol 2003; 43(4)365–78
- Daley-Yates P T, Price A C, Sisson J R, Pereira A, Dallow N. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol 2001; 51(5)400–9
- Vanden Burgt J A, Busse W W, Martin R J, Szefler S J, Donnell D. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. J Allergy Clin Immunol 2000; 106(6)1209–26